Picture of Percheron Therapeutics logo

PER — Percheron Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Antisense Therapeutics Says Mark Diamond Advised Of Retirement As CEO

Nov 15 (Reuters) - Antisense Therapeutics Ltd  ANP.AX :
    * ANTISENSE THERAPEUTICS CEO ANNOUNCES RETIREMENT
    * CHIEF EXECUTIVE OFFICER AND MANAGING DIRECTOR, MARK
DIAMOND HAS
ADVISED THAT HE IS RETIRING AS CEO

Source text for Eikon:  ID:nASX9xw17B 
Further company coverage:  ANP.AX 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Percheron Therapeutics

See all news